# TNG Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tng-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Louisville, US
- Website: www.flyvax.com
- Total disclosed funding: $4.6M
- Latest round: Series A (Feb 6, 2014)
- Investors on record: 7

## About

TNG Pharmaceuticals, Inc. is the US-based company and operates as a developer of patented vaccine that reduces the horn fly population.

## Funding rounds

- Series A, Feb 6, 2014, $4.6M — University of Louisville Foundation, The Houston Angel Network, Bluegrass Angels, AIM Group, Yearling Management, GOOSE Capital, Paul Ogle Foundation, Inc.

## Investors

- University of Louisville Foundation — Series A
- The Houston Angel Network — Series A
- Bluegrass Angels (https://capitalatlas.ai/funds/bluegrass-angels) — Series A
- AIM Group — Series A
- Yearling Management (https://capitalatlas.ai/funds/yearling-management) — Series A
- GOOSE Capital (https://capitalatlas.ai/funds/goose-capital) — Series A
- Paul Ogle Foundation, Inc. — Series A